Cargando…
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
The current review describes the development, clinical relevance and potential caveats of polygenic risk scores (PRS) for LDL cholesterol (LDL-C). RECENT FINDINGS: In recent years, a large number of common variants have been shown to have a small effect on LDL-C levels. The aggregate effect of all o...
Autores principales: | Cupido, Arjen J., Tromp, Tycho R., Hovingh, G. Kees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984749/ https://www.ncbi.nlm.nih.gov/pubmed/33560669 http://dx.doi.org/10.1097/MOL.0000000000000741 |
Ejemplares similares
-
The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case
por: Wand, Hannah, et al.
Publicado: (2021) -
DNA methylation in human lipid metabolism and related diseases
por: Mittelstraß, Kirstin, et al.
Publicado: (2018) -
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018) -
Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
por: Sherratt, Samuel C.R., et al.
Publicado: (2020) -
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
por: Glatz, Jan F.C., et al.
Publicado: (2022)